Delivery Order SPE2DB20D2014-SPE2DB25FC61R
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,808.85 to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100-count units) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Premarin, a hormone replacement therapy medication, falls within the...
- The Defense Logistics Agency awarded a delivery order valued at $12,904.49 to AmerisourceBergen Drug Corp for 1,000 tablets of Premarin 1.25 mg on July 23, 2025, with an ultimate completion date of July 24, 2025. This contract utilizes firm fixed-price pricing and was awarded on a competitive, non-set-aside basis. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $8,600.44 to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.625 mg on July 25, 2025, with an ultimate completion date of July 28, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a delivery order, this award is issued under a larger...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Premarin 30GM CR 1S, a hormone replacement therapy medication. This firm fixed-price delivery order, valued at $4,952.89, was competitively awarded without set-aside provisions and is scheduled for completion by July 28, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,609.28 to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.3 mg on July 24, 2025. The contract employs firm fixed price pricing with no set-aside designation, indicating competitive award. Performance is scheduled for completion by July 25, 2025, with work to be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Premarin is a conjugated estrogen hormone replacement therapy...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 1,000 units of the 0.3 mg tablet form of the pharmaceutical Premarin. The order has a potential value of $29,912.66 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is part of a larger indefinite delivery contract (IDC) awarded by DLA with a potential value of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Premarin 0.3 mg tablets (100-count units) with a ceiling value of $4,722.10. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The contract is scheduled for ultimate completion by July 24, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on July 25, 2025, to supply 1,000 tablets of Premarin 0.625 mg at a fixed price of $3,251.40, with completion scheduled for July 28, 2025. This non-set-aside, competitively awarded contract represents a routine pharmaceutical procurement supporting federal medical supply needs. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- This is a delivery order under Contract SPE2DB20D2104 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $1,455.96 firm fixed-price delivery order is for 100 tablets of Premarin 0.625 mg, a prescription hormone medication. The award has no set-aside designation, indicating full and open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a broad range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Premarin 0.625 mg tablets, a hormone treatment medication, with a ceiling value of $15,707.12 and a period of performance through April 2025. The contract is not designated as a set-aside and is a firm fixed-price delivery order. AmerisourceBergen holds a larger Indefinite Delivery...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC61RDelivery Order
The Defense Logistics Agency awarded a $15,612.00 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Premarin 0.625 mg, a hormone replacement therapy medication. This competitively awarded, firm fixed-price contract includes performance at AmerisourceBergen's Conshohocken, Pennsylvania facility with an ultimate completion date of August 1, 2025. The delivery order carries no set-aside designation, reflecting the company's demonstrated capability to compete openly for federal pharmaceutical procurement requirements. This delivery order is executed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which holds a $999,999,999.00 potential value through December 2026. This prime contract vehicle supports the Defense Health Agency and other federal healthcare systems by enabling flexible pharmaceutical sourcing across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and related medical supplies on a global basis. The award demonstrates AmerisourceBergen's established role as a critical pharmaceutical distributor within the federal military healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.6k | 7/31/25 |